IBA Molecular is leading the future of Molecular Imaging by leveraging our core expertise to deliver unique innovation and a complete product portfolio through our worldwide delivery network.
With the ultimate mission of protecting, enhancing and saving lives, we are capitalizing on the expertise of our Medical Advisory Board, key opinion leaders in the molecular imaging field, and innovators in molecular imaging to bring key diagnostic imaging agents to patients around the world. From our current product portfolio, which we deliver with the highest reliability, to our participation in a Phase III clinical trial for the G-250 clear cell renal carcinoma imaging agent, we are proactively redefining the standards of diagnosis through molecular imaging.
© IBA 2009 | All rights reserved |
